We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
112 hedge funds and large institutions have $36.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 42 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
7,200% more call options, than puts
Call options by funds: $146K | Put options by funds: $2K
12% less funds holding
Funds holding: 127 → 112 (-15)
38% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 42
48% less capital invested
Capital invested by funds: $69.9M → $36.7M (-$33.3M)
58% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 26
Holders
112
Holders Change
-15
Holders Change %
-11.81%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
26
Reduced
42
Closed
26
Calls
$146K
Puts
$2K
Net Calls
+$144K
Net Calls Change
-$173K
Top Buyers
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$114K |
| 2 |
Jane Street
New York
|
+$104K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$98.5K |
| 4 |
E
Ergoteles
New York
|
+$86.6K |
| 5 |
JP Morgan Chase
New York
|
+$79.5K |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$480K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$441K |
| 3 |
Millennium Management
New York
|
-$429K |
| 4 |
State Street
Boston,
Massachusetts
|
-$416K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$322K |
